Targeting visceral adiposity with pharmacotherapy - PubMed (original) (raw)
Comment
Targeting visceral adiposity with pharmacotherapy
Kishore M Gadde et al. Lancet Diabetes Endocrinol. 2021 Sep.
No abstract available
Comment on
- Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.
Neeland IJ, Marso SP, Ayers CR, Lewis B, Oslica R, Francis W, Rodder S, Pandey A, Joshi PH. Neeland IJ, et al. Lancet Diabetes Endocrinol. 2021 Sep;9(9):595-605. doi: 10.1016/S2213-8587(21)00179-0. Epub 2021 Aug 3. Lancet Diabetes Endocrinol. 2021. PMID: 34358471 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources